PIASy-mediated repression of the androgen receptor is independent of sumoylation
- 23 February 2004
- journal article
- Published by Springer Nature in Oncogene
- Vol. 23 (17), 3059-3066
- https://doi.org/10.1038/sj.onc.1207443
Abstract
PIASy, a member of the protein inhibitor of activated STAT (PIAS) family, represses the transcriptional activity of the androgen receptor (AR). In this report, we investigate the mechanism of PIASy-mediated repression of AR. We show that AR binds to the RING-finger like domain of PIASy. PIASy contains two transcriptional repression domains, RD1 and RD2. RD1, but not RD2, is required for PIASy-mediated repression of AR. We show that the RD1 domain binds HDAC1 and HDAC2 and that HDAC activity is required for PIASy-mediated AR repression. PIAS proteins possess small ubiquitin-related modifier (SUMO) E3 ligase activity. Conjugation of SUMO-1 to AR has been implicated in the regulation of AR activity. We examine if the SUMO ligase activity of PIASy is required for PIASy to repress AR. We show that a mutant PIASy, defective in promoting sumoylation, retains the ability to repress AR transcription. In addition, mutation of all the known sumoylation acceptor sites of AR does not affect the transrepression activity of PIASy on AR. Our results suggest that PIASy may repress AR by recruiting histone deacetylases, independent of its SUMO ligase activity.Keywords
This publication has 31 references indexed in Scilit:
- Regulation of JAK–STAT signalling in the immune systemNature Reviews Immunology, 2003
- PIAS1 and PIASxα Function as SUMO-E3 Ligases toward Androgen Receptor and Repress Androgen Receptor-dependent TranscriptionJournal of Biological Chemistry, 2002
- PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 LigasesMolecular and Cellular Biology, 2002
- Protein Inhibitors of Activated STAT Resemble Scaffold Attachment Factors and Function as Interacting Nuclear Receptor CoregulatorsJournal of Biological Chemistry, 2002
- Molecular Engineering of a Two-Step Transcription Amplification (TSTA) System for Transgene Delivery in Prostate CancerMolecular Therapy, 2002
- PIASy, a nuclear matrix–associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodiesGenes & Development, 2001
- Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectorsGene Therapy, 2001
- Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cellsOncogene, 2001
- Cooperative Assembly of Androgen Receptor into a Nucleoprotein Complex That Regulates the Prostate-specific Antigen EnhancerJournal of Biological Chemistry, 1999
- Coactivator and corepressor complexes in nuclear receptor functionCurrent Opinion in Genetics & Development, 1999